Vir Biotechnology, Inc.
Public company- Headquarters
- SAN FRANCISCO, California
- Industry
- Biotechnology
- Ticker
- VIR
- CIK
- 0001706431
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class III directorSuzanne Topalian, M.D. | Oct 28, 2026 | Appointed |
| CFOAziz Sawaf | Oct 1, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- AMGEN INC
director appointed: David W. Gibbs
- Cardiff Oncology, Inc.
CMO appointed: Leila Alland
- Vaxart, Inc.
member of the Board appointed: Raquel C. Bono, M.D., M.B.A., FACS
- Caribou Biosciences, Inc.
Plant closure: Berkeley, CA
- Executive appointment
Class III director appointed: Suzanne Topalian, M.D.
Suzanne Topalian, M.D. was named Class III director of Vir Biotechnology, Inc., effective October 27, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 28, 2026Role: Class III director
- Executive appointment
CFO appointed: Aziz Sawaf
Aziz Sawaf was named Executive Vice President and Chief Financial Officer of Vir Biotechnology, Inc., effective October 5, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 1, 2026Role: Executive Vice President and Chief Financial Officer
Last verified Nov 8, 2026